Hydroxyeicosapentaenoic acids from the Pacific krill show high ligand activities for PPARs

Journal of Lipid Research

Volumn 55, Issue 5, 2014, Pages 895-904

  Yamada, Hidetoshi ^a   Oshiro, Eriko ^a   Kikuchi, Sayaka ^a   Hakozaki, Mayuka ^a   Takahashi, Hideyuki ^a   Kimura, Ken Ichi ^b  

^a IWATE BIOTECHNOLOGY RESEARCH CENTER   (Japan)

^b IWATE UNIVERSITY   (Japan)

Author keywords

Adipogenesis; Fatty acid oxidation; Glucose uptake; Peroxisome proliferator acitivated receptor

Indexed keywords

12 HYDROXYEICOSAPENTAENOIC ACID; 18 HYDROXYEICOSAPENTAENOIC ACID; 5 HYDROXYEICOSAPENTAENOIC ACID; 8 HYDROXYEICOSAPENTAENOIC ACID; 9 HYDROXYEICOSAPENTAENOIC ACID; ANGIOPOIETIN; ANGIOPOIETIN LIKE PROTEIN 4; HYDROXYEICOSAPENTAENOIC ACID; ICOSANOID; ICOSAPENTAENOIC ACID; ICOSAPENTAENOIC ACID ETHYL ESTER; PEROXISOME PROLIFERATOR ACTIVATED RECEPTOR; PEROXISOME PROLIFERATOR ACTIVATED RECEPTOR ALPHA; PEROXISOME PROLIFERATOR ACTIVATED RECEPTOR DELTA; PEROXISOME PROLIFERATOR ACTIVATED RECEPTOR GAMMA; UNCLASSIFIED DRUG; ANGPTL4 PROTEIN, MOUSE; FATTY ACID; GLUCOSE; LIGAND;

ADIPOGENESIS; ANIMAL CELL; ARTICLE; CONTROLLED STUDY; EUPHAUSIA; EUPHAUSIA PACIFICA; FATTY ACID OXIDATION; GENE EXPRESSION; GLUCOSE TRANSPORT; MOUSE; MYOBLAST; NONHUMAN; PRIORITY JOURNAL; PROADIPOCYTE; TRANSCRIPTION INITIATION; ANIMAL; CELL LINE; CHEMISTRY; DRUG EFFECTS; GENETICS; HUMAN; KRILL; METABOLISM; MITOCHONDRION; OXIDATION REDUCTION REACTION; PEROXISOME; TRANSPORT AT THE CELLULAR LEVEL;

ADIPOGENESIS; ANGIOPOIETINS; ANIMALS; BIOLOGICAL TRANSPORT; CELL LINE; EICOSAPENTAENOIC ACID; EUPHAUSIACEA; FATTY ACIDS; GLUCOSE; HUMANS; LIGANDS; MICE; MITOCHONDRIA; MYOBLASTS; OXIDATION-REDUCTION; PEROXISOME PROLIFERATOR-ACTIVATED RECEPTORS; PEROXISOMES; TRANSCRIPTIONAL ACTIVATION;

EID: 84899545016     PISSN: 00222275     EISSN: 15397262     Source Type: Journal    
DOI: 10.1194/jlr.M047514     Document Type: Article

References (52)

1. Schoonjans, K., B. Staels, and J. Auwerx. 1996. The peroxisome proliferator activated receptors (PPARS) and their effects on lipid metabolism and adipocyte differentiation. Biochim. Biophys. Acta. 1302 : 93-109.
2. Tugwood, J. D., I. Issemann, R. G. Anderson, K. R. Bundell, W. L. McPheat, and S. Green. 1992. The mouse peroxisome proliferator activated receptor recognizes a response element in the 5' flanking sequence of the rat acyl CoA oxidase gene. EMBO J. 11 : 433-439.
3. Zhang, B., S. L. Marcus, F. G. Sajjadi, K. Alvares, J. K. Reddy, S. Subramani, R. A. Rachubinski, and J. P. Capone. 1992. Identification of a peroxisome proliferator-responsive element upstream of the gene encoding rat peroxisomal enoyl-CoA hydratase/3-hydroxyacyl-CoA dehydrogenase. Proc. Natl. Acad. Sci. USA. 89 : 7541-7545.
4. Kliewer, S. A., S. S. Sundseth, S. A. Jones, P. J. Brown, G. B. Wisely, C. S. Koble, P. Devchand, W. Wahli, T. M. Willson, J. M. Lenhard, et al. 1997. Fatty acids and eicosanoids regulate gene expression through direct interactions with peroxisome proliferator-activated receptors alpha and gamma. Proc. Natl. Acad. Sci. USA. 94 : 4318-4323.
5. Marcus, S. L., K. S. Miyata, B. Zhang, S. Subramani, R. A. Rachubinski, and J. P. Capone. 1993. Diverse peroxisome proliferator-activated receptors bind to the peroxisome proliferatorresponsive elements of the rat hydratase/dehydrogenase and fatty acyl-CoA oxidase genes but differentially induce expression. Proc. Natl. Acad. Sci. USA. 90 : 5723-5727.
6. Bernal-Mizrachi, C., S. Weng, C. Feng, B. N. Finck, R. H. Knutsen, T. C. Leone, T. Coleman, R. P. Mecham, D. P. Kelly, and C. F. Semenkovich. 2003. Dexamethasone induction of hypertension and diabetes is PPAR-alpha dependent in LDL receptor-null mice. Nat. Med. 9 : 1069-1075.
7. Reddy, J. K., and T. Hashimoto. 2001. Peroxisomal beta-oxidation and peroxisome proliferator-activated receptor alpha: an adaptive metabolic system. Annu. Rev. Nutr. 21 : 193-230.
8. Forman, B. M., J. Chen, and R. M. Evans. 1997. Hypolipidemic drugs, polyunsaturated fatty acids, and eicosanoids are ligands for peroxisome proliferator-activated receptors alpha and delta. Proc. Natl. Acad. Sci. USA. 94 : 4312-4317.
9. Desvergne, B., and W. Wahli. 1999. Peroxisome proliferator-activated receptors: nuclear control of metabolism. Endocr. Rev. 20 : 649-688.
10. Lee, S. S., T. Pineau, J. Drago, E. J. Lee, J. W. Owens, D. L. Kroetz, P. M. Fernandez-Salguero, H. Westphal, and F. J. Gonzalez. 1995. Targeted disruption of the alpha isoform of the peroxisome proliferator-activated receptor gene in mice results in abolishment of the pleiotropic effects of peroxisome proliferators. Mol. Cell. Biol. 15 : 3012-3022.
11. Tontonoz, P., E. Hu, R. A. Graves, A. I. Budavari, and B. M. Spiegelman. 1994. mPPAR gamma 2: tissue-specific regulator of an adipocyte enhancer. Genes Dev. 8: 1224-1234.
12. Rosen, E. D., and B. M. Spiegelman. 2001. PPARgamma: a nuclear regulator of metabolism, differentiation, and cell growth. J. Biol. Chem. 276 : 37731-37734.
13. Kliewer, S. A., B. M. Forman, B. Blumberg, E. S. Ong, U. Borgmeyer, D. J. Mangelsdorf, K. Umesono, and R. M. Evans. 1994. Differential expression and activation of a family of murine peroxisome proliferator-activated receptors. Proc. Natl. Acad. Sci. USA. 91 : 7355-7359.
14. Amri, E. Z., F. Bonino, G. Ailhaud, N. A. Abumrad, and P. A. Grimaldi. 1995. Cloning of a protein that mediates transcriptional effects of fatty acids in preadipocytes. Homology to peroxisome proliferator-activated receptors. J. Biol. Chem. 270 : 2367-2371.
15. Braissant, O., F. Foufelle, C. Scotto, M. Dauça, and W. Wahli. 1996. Differential expression of peroxisome proliferator-activated receptors (PPARs): tissue distribution of PPAR-alpha, -beta, and -gamma in the adult rat. Endocrinology. 137 : 354-366.
16. Wang, Y-X., C-L. Zhang, R. T. Yu, H. K. Cho, M. C. Nelson, C. R. Bayuga-Ocampo, J. Ham, H. Kang, and R. M. Evans. 2004. Regulation of muscle fiber type and running endurance by PPARdelta. PLoS Biol. 2 : e294.
17. Forman, B. M., P. Tontonoz, J. Chen, R. P. Brun, B. M. Spiegelman, and R. M. Evans. 1995. 15-Deoxy-delta 12, 14-prostaglandin J2 is a ligand for the adipocyte determination factor PPAR gamma. Cell. 83 : 803-812.
18. Dowell, P., V. J. Peterson, T. M. Zabriskie, and M. Leid. 1997. Ligand-induced peroxisome proliferator-activated receptor alpha conformational change. J. Biol. Chem. 272 : 2013-2020.
19. Krey, G., O. Braissant, F. L'Horset, E. Kalkhoven, M. Perroud, M. G. Parker, and W. Wahli. 1997. Fatty acids, eicosanoids, and hypolipidemic agents identified as ligands of peroxisome proliferatoractivated receptors by coactivator-dependent receptor ligand assay. Mol. Endocrinol. 11 : 779-791.
20. Yu, K., W. Bayona, C. B. Kallen, H. P. Harding, C. P. Ravera, G. McMahon, M. Brown, and M. A. Lazar. 1995. Differential activation of peroxisome proliferator-activated receptors by eicosanoids. J. Biol. Chem. 270 : 23975-23983.
21. Johnson, T. E., M. K. Holloway, R. Vogel, S. J. Rutledge, J. J. Perkins, G. A. Rodan, and A. Schmidt. 1997. Structural requirements and cell-type specificity for ligand activation of peroxisome proliferatoractivated receptors. J. Steroid Biochem. Mol. Biol. 63 : 1-8.
22. Kliewer, S. A., J. M. Lenhard, T. M. Willson, I. Patel, D. C. Morris, and J. M. Lehmann. 1995. A prostaglandin J2 metabolite binds peroxisome proliferator-activated receptor gamma and promotes adipocyte differentiation. Cell. 83 : 813-819.
23. Devchand, P. R., H. Keller, J. M. Peters, M. Vazquez, F. J. Gonzalez, and W. Wahli. 1996. The PPARalpha-leukotriene B4 pathway to inflammation control. Nature. 384 : 39-43.
24. Durrington, P. N. 1993. Diabetes, hypertension and hyperlipidaemia. Postgrad. Med. J. 69(Suppl 1): S18-S25; discussion S25-S29.
25. Reaven, G. M. 1994. Syndrome X: 6 years later. J. Intern. Med. Suppl. 736 : 13-22.
26. Willumsen, N., J. Skorve, S. Hexeberg, A. C. Rustan, and R. K. Berge. 1993. The hypotriglyceridemic effect of eicosapentaenoic acid in rats is reflected in increased mitochondrial fatty acid oxidation followed by diminished lipogenesis. Lipids. 28 : 683-690.
27. Spady, D. K., L. A. Woollett, and J. M. Dietschy. 1993. Regulation of plasma LDL-cholesterol levels by dietary cholesterol and fatty acids. Annu. Rev. Nutr. 13 : 355-381.
28. Green, S. 1995. PPAR: a mediator of peroxisome proliferator action. Mutat. Res. 333 : 101-109.
29. Jump, D. B., S. D. Clarke, A. Thelen, and M. Liimatta. 1994. Coordinate regulation of glycolytic and lipogenic gene expression by polyunsaturated fatty acids. J. Lipid Res. 35 : 1076-1084.
30. Vigerust, N. F., B. Bjørndal, P. Bohov, T. Brattelid, A. Svardal, and R. K. Berge. 2013. Krill oil versus fish oil in modulation of inflammation and lipid metabolism in mice transgenic for TNF-α. Eur. J. Nutr. 52 : 1315-1325.
31. Ierna, M., A. Kerr, H. Scales, K. Berge, and M. Griinari. 2010. Supplementation of diet with krill oil protects against experimental rheumatoid arthritis. BMC Musculoskelet. Disord. 11 : 136.
32. Sadzuka, Y., I. Sugiyama, M. Miyashita, T. Ueda, S. Kikuchi, E. Oshiro, A. Yano, and H. Yamada. 2012. Beneficial effects by intake of Euphausiacea pacifica on high-fat diet-induced obesity. Biol. Pharm. Bull. 35 : 568-572.
33. Vanden Heuvel, J. P., D. Kreder, B. Belda, D. B. Hannon, C. A. Nugent, K. A. Burns, and M. J. Taylor. 2003. Comprehensive analysis of gene expression in rat and human hepatoma cells exposed to the peroxisome proliferator WY14,643. Toxicol. Appl. Pharmacol. 188 : 185-198.
34. Staiger, H., C. Haas, J. Machann, R. Werner, M. Weisser, F. Schick, F. Machicao, N. Stefan, A. Fritsche, and H-U. Häring. 2009. Musclederived angiopoietin-like protein 4 is induced by fatty acids via peroxisome proliferator-activated receptor (PPAR)-delta and is of metabolic relevance in humans. Diabetes. 58 : 579-589.
35. Robciuc, M. R., P. Skrobuk, A. Anisimov, V. M. Olkkonen, K. Alitalo, R. H. Eckel, H. A. Koistinen, M. Jauhiainen, and C. Ehnholm. 2012. Angiopoietin-like 4 mediates PPAR delta effect on lipoprotein lipase-dependent fatty acid uptake but not on beta-oxidation in myotubes. PLoS ONE. 7 : e46212.
36. Krämer, D. K., L. Al-Khalili, S. Perrini, J. Skogsberg, P. Wretenberg, K. Kannisto, H. Wallberg-Henriksson, E. Ehrenborg, J. R. Zierath, and A. Krook. 2005. Direct activation of glucose transport in primary human myotubes after activation of peroxisome proliferatoractivated receptor delta. Diabetes. 54 : 1157-1163.
37. Groop, L. C., R. C. Bonadonna, D. C. Simonson, A. S. Petrides, M. Shank, and R. A. DeFronzo. 1992. Effect of insulin on oxidative and nonoxidative pathways of free fatty acid metabolism in human obesity. Am. J. Physiol. 263 : E79-E84.
38. Richieri, G. V, and A. M. Kleinfeld. 1995. Unbound free fatty acid levels in human serum. J. Lipid Res. 36 : 229-240.
39. Kubota, N., Y. Terauchi, H. Miki, H. Tamemoto, T. Yamauchi, K. Komeda, S. Satoh, R. Nakano, C. Ishii, T. Sugiyama, et al. 1999. PPAR gamma mediates high-fat diet-induced adipocyte hypertrophy and insulin resistance. Mol. Cell. 4 : 597-609.
40. Tsuchida, A., T. Yamauchi, S. Takekawa, Y. Hada, Y. Ito, T. Maki, and T. Kadowaki. 2005. Peroxisome proliferator-activated receptor (PPAR)alpha activation increases adiponectin receptors and reduces obesity-related inflammation in adipose tissue: comparison of activation of PPARalpha, PPARgamma, and their combination. Diabetes. 54 : 3358-3370.
41. Wang, Y-X., C-H. Lee, S. Tiep, R. T. Yu, J. Ham, H. Kang, and R. M. Evans. 2003. Peroxisome-proliferator-activated receptor delta activates fat metabolism to prevent obesity. Cell. 113 : 159-170.
42. Rosenson, R. S. 2008. Fenofibrate: treatment of hyperlipidemia and beyond. Expert Rev. Cardiovasc. Ther. 6 : 1319-1330.
43. Jeong, S., and M. Yoon. 2009. Fenofibrate inhibits adipocyte hypertrophy and insulin resistance by activating adipose PPARalpha in high fat diet-induced obese mice. Exp. Mol. Med. 41 : 397-405.
44. Guerre-Millo, M., P. Gervois, E. Raspé, L. Madsen, P. Poulain, B. Derudas, J. M. Herbert, D. A. Winegar, T. M. Willson, J. C. Fruchart, et al. 2000. Peroxisome proliferator-activated receptor alpha activators improve insulin sensitivity and reduce adiposity. J. Biol. Chem. 275 : 16638-16642.
45. Brown, K. K., B. R. Henke, S. G. Blanchard, J. E. Cobb, R. Mook, I. Kaldor, S. A. Kliewer, J. M. Lehmann, J. M. Lenhard, W. W. Harrington, et al. 1999. A novel N-aryl tyrosine activator of peroxisome proliferator-activated receptor-gamma reverses the diabetic phenotype of the Zucker diabetic fatty rat. Diabetes. 48 : 1415-1424.
46. Tanaka, T., J. Yamamoto, S. Iwasaki, H. Asaba, H. Hamura, Y. Ikeda, M. Watanabe, K. Magoori, R. X. Ioka, K. Tachibana, et al. 2003. Activation of peroxisome proliferator-activated receptor delta induces fatty acid beta-oxidation in skeletal muscle and attenuates metabolic syndrome. Proc. Natl. Acad. Sci. USA. 100 : 15924-15929.
47. Morita, I., R. Takahashi, Y. Saito, and S. Murota. 1983. Stimulation of eicosapentaenoic acid metabolism in washed human platelets by 12-hydroperoxyeicosatetraenoic acid. J. Biol. Chem. 258 : 10197-10199.
48. Rose, F., L. Kiss, F. Grimminger, K. Mayer, U. Grandel, W. Seeger, E. Bieniek, and U. Sibelius. 2000. E. coli hemolysin-induced lipid mediator metabolism in alveolar macrophages: impact of eicosapentaenoic acid. Am. J. Physiol. Lung Cell. Mol. Physiol. 279 : L100-L109.
49. Dioszeghy, V., M. Rosas, B. H. Maskrey, C. Colmont, N. Topley, P. Chaitidis, H. Kühn, S. A. Jones, P. R. Taylor, and V. B. O'Donnell. 2008. 12/15-Lipoxygenase regulates the inflammatory response to bacterial products in vivo. J. Immunol. 181 : 6514-6524.
50. Hwang, D. H., M. Boudreau, and P. Chanmugam. 1988. Dietary linolenic acid and longer-chain n-3 fatty acids: comparison of effects on arachidonic acid metabolism in rats. J. Nutr. 118 : 427-437.
51. Tomio, K., K. Kawana, A. Taguchi, Y. Isobe, R. Iwamoto, A. Yamashita, S. Kojima, M. Mori, T. Nagamatsu, T. Arimoto, et al. 2013. Omega-3 polyunsaturated fatty acids suppress the cystic lesion formation of peritoneal endometriosis in transgenic mouse models. PLoS ONE. 8 : e73085.
52. Fürstenberger, G., F. Marks, and P. Krieg. 2002. Arachidonate 8(S)-lipoxygenase. Prostaglandins Other Lipid Mediat. 68-69 : 235-243.